Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation.

Trial Profile

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Daclizumab; Methylprednisolone; Prednisolone
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Acronyms CHASE
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 14 Apr 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Actual patient number (138) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top